Hiroshi Shiragami
Ajinomoto
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroshi Shiragami.
Nucleosides, Nucleotides & Nucleic Acids | 1995
Hiroshi Shiragami; Yoshihito Koguchi; Yasuhiro Tanaka; Satoshi Takamatsu; Yumiko Uchida; Takashi Ineyama; Kunisuke Izawa
Abstract A convenient synthesis of 9-(2-hydroxyethoxymethyl)guanine (acyclovir) from guanosine by chemical transpurination was developed. The isomerization of the 7-isomer to the desired 9-isomer and the purification of the 9-isomer was achieved simply by concentration, heating and further crystallization.
Nucleosides, Nucleotides & Nucleic Acids | 1996
Hiroshi Shiragami; Takashi Ineyama; Yumiko Uchida; Kunisuke Izawa
Abstract A practical synthetic method of d4T (3) from 5-methyluridine (2a) was developed. The Marumoto-Mansuri method was modified using 2′,3′-O-methoxy-ethylidene-5-methyluridine (10) as an intermediate to afford 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-ribofuranosyl)thymine (6a) in high yield with less formation of by-products. The reaction mechanism was also discussed. †Dedicated to Dr. Yoshihisa Mizuno on the occasion of his 75th birthday.
Nucleosides, Nucleotides & Nucleic Acids | 1992
Hiroshi Shiragami; Yasuhiro Tanaka; Yumiko Uchida; Hisao Iwagami; Kunisuke Izawa; Toshihide Yukawa
Abstract Regioselective 2′-O-deacetylation of 9-(2,5-di-O-acetyl-3-bromo-3-deoxy-β-D-xylofuranosyl)adenine (1) is achieved by treatment of 1 with β-cyclodextrin (β-CyD) / aq. NaHCO3 or N2H4·H2O / EtOH. The 9-(5-O-Acetyl-3-bromo-3-deoxy-β-D-xylo-furanosyl)adenine (2) obtained is a common intermediate for the synthesis of 2′,3′-dideoxy-adenosine (ddA) (7) and 9-(2-fluoro-2,3-dideoxy-β-D-threo-pentofuranosyl)-adenine (F-ddA) (9).
Pure and Applied Chemistry | 1998
Kunisuke Izawa; Hiroshi Shiragami
Guanosine produced by fermentation is one of the nucleosides most readily available on an industrial scale. We have recently developed several processes leading to known antiviral agents starting with guanosine. The processes involve enzymatic transglycosylation for stavudine (d4T), chemical transpurination for acyclovir and ganciclovir, and novel alkylauon for penciclovir and famciclovir.
Nucleosides, Nucleotides & Nucleic Acids | 1996
Hiroshi Shiragami; Yusuke Amino; Yutaka Honda; Masayuki Arai; Yasuhiro Tanaka; Hisao Iwagami; Toshihide Yukawa; Kunisuke Izawa
Abstract Practical method to produce 2′,3′-dideoxypurinenucleosides from 9-(2,5-di-O-acetyl-3-bromo-3-deoxy-β-D-xylofuranosyl)purines (1) was developed. High ratio of 2′,3′-dideoxynucleoside to 3′-deoxyribonucleoside was obtained by selecting the reaction conditions (solvent, pH and/or base), or changing 2′-acyloxy leaving group. The reaction mechanism was studied by deuteration experiments of 1a and 1-(3,5-di-O-acety1-2-bromo-2-deoxy-β-D-ribofuranosyl)thymine (12). †Dedicated to Dr. Yoshihisa Mizuno on the occasion of his 75th birthday.
Nucleosides, Nucleotides & Nucleic Acids | 1999
Toyoto Hijiya; Keizo Yamashita; Mitsuhiko Kojima; Yumiko Uchida; Satoshi Katayama; Takayoshi Torii; Hiroshi Shiragami; Kunisuke Izawa
An economical synthesis of famciclovir from N-2-acetyl-7-benzylguanine by a novel regioselective alkylation with the diester cyclopropane compound was developed.
Archive | 1999
Kunisuke Izawa; Hiroshi Shiragami; Keizo Yamashita
Archive | 1993
Hiroshi Shiragami; Yasuo Irie; Naohiko Yasuda
Archive | 1994
Kunisuke Izawa; Yoshihito Koguchi; Hiroshi Shiragami
Archive | 1992
Yutaka Honda; Hiroshi Shiragami; Hisao Iwagami; Masayuki Arai